311 related articles for article (PubMed ID: 30278528)
1. Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.
Man KM; Chen KB; Chen HY; Chiang JH; Su YC; Man SS; Xie DD; Wang Y; Zhang ZQ; Bi LK; Zhang T; Yu DX; Chen WC
Medicine (Baltimore); 2018 Sep; 97(39):e12459. PubMed ID: 30278528
[TBL] [Abstract][Full Text] [Related]
2. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
[TBL] [Abstract][Full Text] [Related]
3. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
[TBL] [Abstract][Full Text] [Related]
4. 5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study.
Lee SS; Yang YW; Tsai TH; Kuo YH; Chuang HY; Lee CC; Hsieh TF
Prostate; 2016 Jan; 76(1):41-7. PubMed ID: 26390988
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
Tseng CH
BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
[TBL] [Abstract][Full Text] [Related]
6. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan.
Sung SY; Le TTH; Chen JH; Hsieh TF; Hsieh CL
PLoS One; 2020; 15(11):e0242429. PubMed ID: 33211759
[TBL] [Abstract][Full Text] [Related]
8. Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study.
Hsieh TF; Yang YW; Lee SS; Lin TH; Liu HH; Tsai TH; Chen CC; Huang YS; Lee CC
PLoS One; 2015; 10(3):e0119694. PubMed ID: 25803433
[TBL] [Abstract][Full Text] [Related]
9. Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
Fang CW; Liao CH; Wu SC; Muo CH
World J Urol; 2018 Jun; 36(6):931-938. PubMed ID: 29427001
[TBL] [Abstract][Full Text] [Related]
10. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of benign prostate hyperplasia in sleep apnea patients: a nationwide population-based study.
Chou PS; Chang WC; Chou WP; Liu ME; Lai CL; Liu CK; Ku YC; Tsai SJ; Chou YH; Chang WP
PLoS One; 2014; 9(3):e93081. PubMed ID: 24667846
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.
Hu WS; Lin CL
Clin Cardiol; 2018 Oct; 41(10):1374-1378. PubMed ID: 30144121
[TBL] [Abstract][Full Text] [Related]
13. Association Between Erectile Dysfunction and Subsequent Prostate Cancer Development: A Population-Based Cohort Study With Double Concurrent Comparison Groups.
Kok VC; Hsiao YH; Horng JT; Wang KL
Am J Mens Health; 2018 Sep; 12(5):1492-1502. PubMed ID: 29708021
[TBL] [Abstract][Full Text] [Related]
14. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study.
Lin YH; Hou CP; Chen TH; Juang HH; Chang PL; Yang PS; Lin YS; Chen CL; Tsui KH
Clin Interv Aging; 2017; 12():535-541. PubMed ID: 28356725
[TBL] [Abstract][Full Text] [Related]
15. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate; 2017 Jun; 77(9):1029-1035. PubMed ID: 28480542
[TBL] [Abstract][Full Text] [Related]
16. Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study.
Peng YH; Huang CW; Chou CY; Chiou HJ; Chen HJ; Wu TN; Ho WC
Aging Male; 2020 Dec; 23(5):599-606. PubMed ID: 30632854
[TBL] [Abstract][Full Text] [Related]
17. Lower urinary tract symptoms-Benign prostatic hyperplasia may increase the risk of subsequent inguinal hernia in a Taiwanese population: A nationwide population-Based cohort study.
Wu YH; Juan YS; Shen JT; Wang HS; Jhan JH; Lee YC; Geng JH
PLoS One; 2020; 15(6):e0234329. PubMed ID: 32511262
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism and thyroid cancer risk: a population-based cohort study.
Yeh NC; Chou CW; Weng SF; Yang CY; Yen FC; Lee SY; Wang JJ; Tien KJ
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):402-6. PubMed ID: 23616188
[TBL] [Abstract][Full Text] [Related]
19. Association of Higher Migraine Risk Among Female and Younger Chronic Osteomyelitis Patients: Evidence from a Taiwan Cohort of One Million.
Chen JH; Wu SC; Muo CH; Kao CH; Tseng CH; Tsai CH
Pain Physician; 2018 Mar; 21(2):E149-E156. PubMed ID: 29565957
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
